CD4 and breast cancer: The ratio of CD4+/CD8+ was significantly decreased in TFG or TFMG-treated groups relative to the control in allograft LLC tumor model (Fig. 4a) as well as in the MMTV-PyMT spontaneous breast cancer model (Fig. 4b).